From a cellular laboratory viewpoint, Relafen 750 ( its salt form) presents a compelling case. Its mechanism of effect primarily involves inhibiting cyclooxygenase catalysts , specifically COX-1 and COX-2, thereby reducing prostaglandin generation. This results in decreased swelling and fever . The drug's relatively long half-life and specific cell